<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000350249"><TermName>TP-38 immunotoxin</TermName><TermPronunciation>(... IH-myoo-noh-TOK-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of brain tumors. It combines a protein that binds to certain tumor cells with a bacterial toxin that kills tumor cells.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711384" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;TP-38 immunotoxin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711385" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inmunotoxina TP-38&quot;" language="es" id="_4"/><SpanishTermName>inmunotoxina TP-38</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de los tumores cerebrales. Combina una proteína que se une a ciertas células tumorales con una toxina bacteriana que destruye células tumorales.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-12-23</DateFirstPublished><DateLastModified>2007-04-06</DateLastModified></GlossaryTerm>
